It’s 2 a.m. A mother calls into a nurse triage line. Her baby isn’t screaming. She’s not rattling off symptoms. She just keeps saying, “something’s wrong.” And the nurse on the other end of that phone ...

Immunology continues to be one of the hottest areas for biotech investment, and Windward Bio is joining in with $165 million in fresh capital to support a pipeline led by a drug in pivotal testing ...

The Trump administration’s crackdown on fraud, waste and abuse continues, with the Department of Justice last week launching a new effort targeting healthcare fraud. Experts think the new strike force ...

Angelini Pharma is acquiring Catalyst Pharmaceuticals in a $4.1 billion deal that gives the Italy-based brain medicines company three commercialized rare disease products and entry into the U.S.

Bayer is paying $300 million to buy Perfuse Therapeutics, a clinical-stage biotech that offers a new growth opportunity in ophthalmology as the pharmaceutical company’s top eye product weathers ...

Rosarium Health, a company enabling aging at home, has raised $6 million in seed funding and secured partnerships with several Medicaid and Medicare Advantage plans, the company shared with MedCity ...